BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 383333)

  • 1. Interactions between IgM antiglobulins and IgG antinuclear antibodies. Some aspects of D-penicillamine activities.
    Mach PS; Piatier D; Le Go A; Delbarre F
    Clin Exp Immunol; 1979 May; 36(2):311-6. PubMed ID: 383333
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Interactions between rheumatoid factors and antinuclear autoantibodies: their occurrence in a concealed state in rheumatoid disease (arthritis); effect of D-penicillamine].
    Mach PS; Delbarre F; Piatier D
    C R Seances Acad Sci D; 1980 Feb; 290(8):575-8. PubMed ID: 6767559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hidden anti-nuclear antibodies in rheumatic diseases.
    Mach PS; Piatier D; Le Go A; Delbarre F
    Clin Exp Immunol; 1980 Feb; 39(2):538-43. PubMed ID: 6993073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure to demonstrate any interaction between polyclonal rheumatoid factors and IgG antinuclear antibodies or other IgG autoantibodies.
    Scott-Morgan L; Lloyd RS
    Clin Exp Immunol; 1980 Aug; 41(2):297-302. PubMed ID: 6160005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A monoclonal anti-idiotype specific for human polyclonal IgM rheumatoid factor.
    Davidson A; Lopez J; Sun D; Prus D
    J Immunol; 1992 Jun; 148(12):3873-8. PubMed ID: 1376343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of anti-cyclic citrullinated peptide antibodies, anti-citrullin antibodies, and IgM and IgA rheumatoid factors with serological parameters of disease activity in rheumatoid arthritis.
    Greiner A; Plischke H; Kellner H; Gruber R
    Ann N Y Acad Sci; 2005 Jun; 1050():295-303. PubMed ID: 16014545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(4):249-57. PubMed ID: 10440996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interference of rheumatoid factor activity by aspartame, a dipeptide methyl ester.
    Ramsland PA; Movafagh BF; Reichlin M; Edmundson AB
    J Mol Recognit; 1999; 12(5):249-57. PubMed ID: 10777254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated levels of IgM and IgA antibodies to Proteus mirabilis and IgM antibodies to Escherichia coli are associated with early rheumatoid factor (RF)-positive rheumatoid arthritis.
    Newkirk MM; Goldbach-Mansky R; Senior BW; Klippel J; Schumacher HR; El-Gabalawy HS
    Rheumatology (Oxford); 2005 Nov; 44(11):1433-41. PubMed ID: 16091399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG rheumatoid factors and anti-nuclear antibodies in rheumatoid vasculitis.
    Quismorio FP; Beardmore T; Kaufman RL; Mongan ES
    Clin Exp Immunol; 1983 May; 52(2):333-40. PubMed ID: 6602676
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect on quinoline derivatives, nucleotides, D-penicillamine,cytostatic and antiphogistic drugs on the rheumatoid factors other immune antibodies].
    Mantel W; Holtz G
    Z Rheumatol; 1975; 34(3-4):94-101. PubMed ID: 1094767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New pathogenetic aspects of rheumatoid arthritis].
    Abendroth K; Wessel G; Steiner G; Schütz I; Spors E
    Z Gesamte Inn Med; 1981 Sep; 36(18):653-6. PubMed ID: 6976046
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating immune complexes and rheumatoid arthritis.
    Faaber P; Rijke Schilder TP; Capel PJ; Koene RA
    J Rheumatol; 1985 Oct; 12(5):849-53. PubMed ID: 3878875
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antinuclear antibodies, patterns and characteristics obtained by immunofluorescence. The importance of the IgA, IgM and IgG isotypes].
    Arcavi M; Dadone J
    Medicina (B Aires); 2009; 69(5):502-6. PubMed ID: 19897433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The stimulation of IgM rheumatoid factor from human B lymphocytes by rheumatoid arthritis complement-activating immune complexes.
    Lorber M; Samuel D; Amlot P; Panayi GS
    Clin Exp Immunol; 1988 Feb; 71(2):275-80. PubMed ID: 3258207
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rheumatoid factors in the pathogenesis of rheumatoid arthritis.
    Mannik M
    J Rheumatol Suppl; 1992 Jan; 32():46-9. PubMed ID: 1613732
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship of serum IgG rheumatoid factor to IgM rheumatoid factor and disease activity in rheumatoid arthritis.
    Robbins DL; Feigal DW; Leek JC
    J Rheumatol; 1986 Apr; 13(2):259-62. PubMed ID: 3723492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Routine measurement of IgM, IgG, and IgA rheumatoid factors: high sensitivity, specificity, and predictive value for rheumatoid arthritis.
    Swedler W; Wallman J; Froelich CJ; Teodorescu M
    J Rheumatol; 1997 Jun; 24(6):1037-44. PubMed ID: 9195506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of induction of antinuclear antibodies by D-penicillamine in rheumatoid arthritis: a controlled study.
    Weinstein A; Rothfield NF
    J Rheumatol; 1986 Apr; 13(2):308-12. PubMed ID: 3487646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug effects on autoantibodies and immune complexes.
    Holborow EJ
    Agents Actions Suppl; 1980; 7():58-61. PubMed ID: 6972690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.